The Middle East spinal cord stimulation device for chronic pain market was valued at US$ 92.79 million in 2022 and is expected to reach US$ 161.65 million by 2030; it is estimated to register at a CAGR of 7.2% from 2022 to 2030.
These advantages aim to make spinal cord stimulation therapy more accessible and acceptable to a broader range of patients, ultimately driving the market growth. Additionally, ongoing research into neuromodulation techniques and targeted therapies may lead to further innovations in the field, offering new treatment options for chronic pain conditions and expanding the potential market for spinal cord stimulators for chronic pain.
These include the Rehabilitation Unit of Prince Sultan Military Medical City of Riyadh, Rehabilitation Unit of King Abdulaziz Medical City, National Guard (Riyadh), Rehabilitation Hospital of King Fahad Medical City (Riyadh), King Saud Medical Complex, Rehabilitation Hospital of Al-Hada Military Hospital (Taif), and Riyadh Care Hospital. With the rising SCI cases among Saudi people, progress in research is expected to result in the rollout of appropriate management programs, effective implementation of primary prevention strategies, and proper allocation of health resources for traumatic conditions.
Technological Advancements Drive Middle East Spinal Cord Stimulation Device for Chronic Pain Market
Traditional spinal cord stimulators require the implantation of electrodes and a pulse generator, which can be invasive and carry certain risks. Wireless technologies, such as high-frequency spinal cord stimulation and dorsal root ganglion stimulation, offer potential advantages in terms of patient comfort, reduced infection risk, and improved outcomes.These advantages aim to make spinal cord stimulation therapy more accessible and acceptable to a broader range of patients, ultimately driving the market growth. Additionally, ongoing research into neuromodulation techniques and targeted therapies may lead to further innovations in the field, offering new treatment options for chronic pain conditions and expanding the potential market for spinal cord stimulators for chronic pain.
Middle East Spinal Cord Stimulation Device for Chronic Pain Market Overview
Middle East spinal cord stimulation device for chronic pain market by region, is segmented as Qatar, Saudi Arabia, UAE, Turkey, Israel, and Rest of Middle East. The rising healthcare claims and associated costs, increasing administrative transactions, and spinal cord stimulation device for chronic pain platform in supply chain tracking are among the prominent factors propelling the market growth. Moreover, various rehabilitation centers have been constructed in Saudi Arabia, as a part of intrinsic modern healthcare delivery services, to overcome challenges posed by a high incidence of SCIs. There are several rehabilitation hospitals/centers in the Kingdom of Saudi Arabia (KSA), mainly in the large cities.These include the Rehabilitation Unit of Prince Sultan Military Medical City of Riyadh, Rehabilitation Unit of King Abdulaziz Medical City, National Guard (Riyadh), Rehabilitation Hospital of King Fahad Medical City (Riyadh), King Saud Medical Complex, Rehabilitation Hospital of Al-Hada Military Hospital (Taif), and Riyadh Care Hospital. With the rising SCI cases among Saudi people, progress in research is expected to result in the rollout of appropriate management programs, effective implementation of primary prevention strategies, and proper allocation of health resources for traumatic conditions.
Middle East Spinal Cord Stimulation Device for Chronic Pain Market Segmentation
The Middle East spinal cord stimulation device for chronic pain market is segmented based on product type, application, end user, and country.- Based on product type, the Middle East spinal cord stimulation device for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held a larger share in 2022.
- In terms of application, the Middle East spinal cord stimulation device for chronic pain market is segmented into failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held the largest share in 2022.
- By end user, the Middle East spinal cord stimulation device for chronic pain market is segmented into hospitals, ambulatory surgery centers (ASCS), and others. The hospitals segment held the largest share in 2022.
- Based on country, the Middle East spinal cord stimulation device for chronic pain market is categorized into Saudi Arabia, Israel, the UAE, Qatar, Turkey, and the Rest of Middle East. Saudi Arabia dominated the Middle East spinal cord stimulation device for chronic pain market in 2022.
Table of Contents
1. Introduction
3. Research Methodology
4. Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Market Landscape
5. Middle East Spinal Cord Stimulation Device for Chronic Pain Market
6. Spinal Cord Stimulation Device for Chronic Pain Market - Middle East Analysis
7. Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 - by Product Type
8. Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by Application
9. Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by End User
10. Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 -Country Analysis
11. Industry Landscape
12. Company Profiles
13. Appendix
Companies Mentioned
- Boston Scientific Corp
- Abbott Laboratories
- Medtronic Plc
- Biotronik SE & Co KG
